Pharma News India

The facility is expected to be the world's largest OTC facility.

Ahmedabad, January 30, 2013: Teva Pharmaceuticals, a US$ 18 billion generic drug maker is setting up an OTC medicine facility in Gujarat in collaboration with Proctor & Gamble. The company had ground-breaking ceremony for its multi-product facility at Sanand, near Ahmedabad on Tuesday.

The pharma company plans to commence the shipping of the product immediately.

New Delhi, January 28, 2013: Glenmark Pharmaceuticals has received the approval from the US health regulator to market Mupirocin Calcium Cream, used for treating skin diseases, in the US. Glenmark Generics Inc, a subsidiary of Glenmark Generics Ltd has been granted the final abbreviated new drug approval...

The Company plans to launch the drug under the Alzumab brand.

New Delhi, January 25, 2013: The Indian biotechnology firm, Biocon, today announced that the company will launch a skin disease drug under the brand Alzumab in India in 2013 and is eying Rs 100 crore in sales over the next four years from the product.

Indian pharma market is expected to clock a 13-14 per cent growth this year.

Mumbai, January 23, 2013: Buoyed by the increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural markets, the Indian pharma market is expected to grow at a compound annual growth rate (CAGR) of 14-17 per cent during 2012-16. In fact, India is now in t...

The Company plans to earn US$ 100 million in the next five years from its new drug.

New Delhi, January 18, 2013: Venus Remedies plans to garner close to US$ 100 million in the next five years from its new drug 'Elores', which is used for combating spread of bacterial resistance. The company also said that it plans to introduce 'Elores' is many other markets post its launch in the ...



* Indicates mandatory field.
Please wait while comments are being sent...